Europe Pharmaceutical Manufacturing Industry 2022-2032 by Formulation, Route of Administration, Consumer Group, Therapeutic Application, Drug Type, Distribution Channel, Manufacturing Facility, and Country: Trend Forecast and Growth Opportunity

December 2023 | 168 pages | ID: E47D74953501EN
GMD Research

Abstracts

Europe pharmaceutical manufacturing industry market was valued at $2.84 billion in 2022 and will grow by 8.6% annually over 2022-2032. The growth is driven by the increased drug approvals, increasing prevalence of chronic ailments, growing geriatric population, high R&D investment in pharmaceutical industry, increasing per capita healthcare expenditure, and technological advancements in manufacturing processes.

Highlighted with 93 tables and 69 figures, this 168-page report “Europe Pharmaceutical Manufacturing Industry 2022-2032 by Formulation, Route of Administration, Consumer Group, Therapeutic Application, Drug Type, Distribution Channel, Manufacturing Facility, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe pharmaceutical manufacturing industry market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe pharmaceutical manufacturing industry market in every aspect of the classification from perspectives of Formulation, Route of Administration, Consumer Group, Therapeutic Application, Drug Type, Distribution Channel, Manufacturing Facility, and Country.

Based on Formulation, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Tablets
• Capsules
• Injectable
• Sprays
• Suspensions
• Powders
• Other Formulations

Based on Route of Administration, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Oral Medicine
• Topical Medicine
• Parenteral Medicine
• Inhalations
• Other Routes of Administration

By Consumer Group, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Children & Adolescents (17 years old and below)
• Adults (18-64 years old)
• Geriatric (65 years old and above)

By Therapeutic Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Cardiovascular Diseases
• Pain
• Diabetes
• Cancer
• Respiratory Diseases
• Neurological Diseases
• Orthopedics
• Other Applications

By Drug Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Branded Prescription Drugs
• Generic Prescription Drugs
• OTC Drugs

By Distribution Channel, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Retail Channels
• Non-retail Channels

By Manufacturing Facility, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• In-house Facility
• Outsourced Facility

Geographically, the following national/local markets are fully investigated:

• Germany
• UK
• France
• Spain
• Italy
• Netherlands
• Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)

For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2032. The breakdown of national markets by Formulation, Route of Administration, and Drug Type over the forecast years are also included.

The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

Abbott Laboratories

Aenova Group

Amgen Inc.

AstraZeneca

Catalent Inc.

Eli Lilly and Company

F. Hoffmann-La Roche Ltd.

Gilead Sciences Inc.

GlaxoSmithKline plc

Johnson & Johnson

Lonza Group

Lupin Limited

Merck & Co., Inc.

Novartis AG

Novo Nordisk

Patheon Inc.

Pfizer CentreSource

Sanofi SA

Takeda

(Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on World Economy
  2.1.2 Impact of COVID-19 on the Market
  2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF EUROPE MARKET BY FORMULATION

3.1 Market Overview by Formulation
3.2 Tablets
3.3 Capsules
3.4 Injectable
3.5 Sprays
3.6 Suspensions
3.7 Powders
3.8 Other Formulations

4 SEGMENTATION OF EUROPE MARKET BY ROUTE OF ADMINISTRATION

4.1 Market Overview by Route of Administration
4.2 Oral Medicine
4.3 Topical Medicine
4.4 Parenteral Medicine
4.5 Inhalations
4.6 Other Routes of Administration

5 SEGMENTATION OF EUROPE MARKET BY CONSUMER GROUP

5.1 Market Overview by Consumer Group
5.2 Children & Adolescents (17 years old and below)
5.3 Adults (18-64 years old)
5.4 Geriatric (65 years old and above)

6 SEGMENTATION OF EUROPE MARKET BY THERAPEUTIC APPLICATION

6.1 Market Overview by Therapeutic Application
6.2 Cardiovascular Diseases
6.3 Pain
6.4 Diabetes
6.5 Cancer
6.6 Respiratory Diseases
6.7 Neurological Diseases
6.8 Orthopedics
6.9 Other Applications

7 SEGMENTATION OF EUROPE MARKET BY DRUG TYPE

7.1 Market Overview by Drug Type
7.2 Branded Prescription Drugs
7.3 Generic Prescription Drugs
7.4 OTC Drugs

8 SEGMENTATION OF EUROPE MARKET BY DISTRIBUTION CHANNEL

8.1 Market Overview by Distribution Channel
8.2 Retail Channels
8.3 Non-retail Channels

9 SEGMENTATION OF EUROPE MARKET BY MANUFACTURING FACILITY

9.1 Market Overview by Manufacturing Facility
9.2 In-house Facility
9.3 Outsourced Facility

10 EUROPEAN MARKET 2022-2032 BY COUNTRY

10.1 Overview of European Market
10.2 Germany
10.3 U.K.
10.4 France
10.5 Spain
10.6 Italy
10.7 Netherlands
10.8 Rest of European Market

11 COMPETITIVE LANDSCAPE

11.1 Overview of Key Vendors
11.2 New Product Launch, Partnership, Investment, and M&A
11.3 Company Profiles
Abbott Laboratories
Aenova Group
Amgen Inc.
AstraZeneca
Catalent Inc.
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Gilead Sciences Inc.
GlaxoSmithKline plc
Johnson & Johnson
Lonza Group
Lupin Limited
Merck & Co., Inc.
Novartis AG
Novo Nordisk
Patheon Inc.
Pfizer CentreSource
Sanofi SA
Takeda
RELATED REPORTS

List Of Tables

LIST OF TABLES

Table 1. Snapshot of Europe Pharmaceutical Manufacturing Industry in Balanced Perspective, 2022-2032
Table 2. World Pharmaceuticals Output by Region, 2022-2025, annual percentage change
Table 3. World Economic Outlook, 2021-2031
Table 4. World Economic Outlook, 2021-2023
Table 5. Scenarios for Economic Impact of Ukraine Crisis
Table 6. World Health Spending by Region, $ bn, 2013-2020
Table 7. Main Product Trends and Market Opportunities in Europe Pharmaceutical Manufacturing Industry
Table 8. Europe Pharmaceutical Manufacturing Industry by Formulation, 2022-2032, $ mn
Table 9. Europe Pharmaceutical Manufacturing Industry by Route of Administration, 2022-2032, $ mn
Table 10. Europe Pharmaceutical Manufacturing Industry by Consumer Group, 2022-2032, $ mn
Table 11. Europe Pharmaceutical Manufacturing Industry by Therapeutic Application, 2022-2032, $ mn
Table 12. Europe Pharmaceutical Manufacturing Industry by Drug Type, 2022-2032, $ mn
Table 13. Europe Pharmaceutical Manufacturing Industry by Distribution Channel, 2022-2032, $ mn
Table 14. Europe Pharmaceutical Manufacturing Industry by Manufacturing Facility, 2022-2032, $ mn
Table 15. Europe Pharmaceutical Manufacturing Industry by Country, 2022-2032, $ mn
Table 16. Germany Pharmaceutical Manufacturing Industry by Formulation, 2022-2032, $ mn
Table 17. Germany Pharmaceutical Manufacturing Industry by Route of Administration, 2022-2032, $ mn
Table 18. Germany Pharmaceutical Manufacturing Industry by Drug Type, 2022-2032, $ mn
Table 19. U.K. Pharmaceutical Manufacturing Industry by Formulation, 2022-2032, $ mn
Table 20. U.K. Pharmaceutical Manufacturing Industry by Route of Administration, 2022-2032, $ mn
Table 21. U.K. Pharmaceutical Manufacturing Industry by Drug Type, 2022-2032, $ mn
Table 22. France Pharmaceutical Manufacturing Industry by Formulation, 2022-2032, $ mn
Table 23. France Pharmaceutical Manufacturing Industry by Route of Administration, 2022-2032, $ mn
Table 24. France Pharmaceutical Manufacturing Industry by Drug Type, 2022-2032, $ mn
Table 25. Spain Pharmaceutical Manufacturing Industry by Formulation, 2022-2032, $ mn
Table 26. Spain Pharmaceutical Manufacturing Industry by Route of Administration, 2022-2032, $ mn
Table 27. Spain Pharmaceutical Manufacturing Industry by Drug Type, 2022-2032, $ mn
Table 28. Italy Pharmaceutical Manufacturing Industry by Formulation, 2022-2032, $ mn
Table 29. Italy Pharmaceutical Manufacturing Industry by Route of Administration, 2022-2032, $ mn
Table 30. Italy Pharmaceutical Manufacturing Industry by Drug Type, 2022-2032, $ mn
Table 31. Netherlands Pharmaceutical Manufacturing Industry by Formulation, 2022-2032, $ mn
Table 32. Netherlands Pharmaceutical Manufacturing Industry by Route of Administration, 2022-2032, $ mn
Table 33. Netherlands Pharmaceutical Manufacturing Industry by Drug Type, 2022-2032, $ mn
Table 34. Pharmaceutical Manufacturing Industry in Rest of Europe by Country, 2022-2032, $ mn
Table 35. Abbott Laboratories: Company Snapshot
Table 36. Abbott Laboratories: Business Segmentation
Table 37. Abbott Laboratories: Product Portfolio
Table 38. Aenova Group: Company Snapshot
Table 39. Aenova Group: Business Segmentation
Table 40. Aenova Group: Revenue by Product, 2018-2019, thousand Euro
Table 41. Aenova Group: Recent Developments
Table 42. Amgen Inc.: Company Snapshot
Table 43. Amgen Inc.: Approved Drugs or Therapeutic Biologicals
Table 44. Astrazeneca: Company Snapshot
Table 45. Catalent Inc.: Company Snapshot
Table 46. Catalent Inc.: Business Segmentation in 2018
Table 47. Catalent Inc.: Product Portfolio
Table 48. Catalent Inc.: Revenue, 2018-2020, $ million
Table 49. Catalent Inc.: Revenue by Region in 2018
Table 50. Eli Lilly and Company: Company Snapshot
Table 51. Eli Lilly and Company: Pharmaceutical Brands
Table 52. F. Hoffmann-La Roche: Company Snapshot
Table 53. F. Hoffmann-La Roche: Business Segmentation
Table 54. F. Hoffmann-La Roche: Revenue, 2017-2019, $ bn
Table 55. Gilead Sciences: Company Snapshot
Table 56. Gilead Sciences: Main Products
Table 57. GlaxoSmithKline: Company Snapshot
Table 58. GlaxoSmithKline: Business Segmentation
Table 59. GlaxoSmithKline: Product Portfolio
Table 60. GlaxoSmithKline: Revenue, 2018-2020, $ bn
Table 61. Johnson & Johnson: Company Snapshot
Table 62. Johnson & Johnson: Business Segments
Table 63. Lonza Group: Company Snapshot
Table 64. Lonza Group: Business Segmentation in 2018
Table 65. Lonza Group: Product Portfolio
Table 66. Lonza Group: Revenue by Region in 2018
Table 67. Lupin Limited: Company Snapshot
Table 68. Lupin Limited: Business Segmentation
Table 69. Merck & Co., Inc.: Company Snapshot
Table 70. Merck & Co., Inc.: Business Segmentation
Table 71. Merck & Co., Inc.: Revenue, 2018-2020, $ bn
Table 72. Novartis International AG: Company Snapshot
Table 73. Novartis International AG: Business Segmentation
Table 74. Novartis International AG: Revenue, 2017-2019, $ bn
Table 75. Novo Nordisk: Company Snapshot
Table 76. Novo Nordisk: Product Portfolio
Table 77. Patheon Inc.: Company Snapshot
Table 78. Patheon Inc.: Business Segmentation in 2018
Table 79. Patheon Inc.: Product Portfolio
Table 80. Patheon Inc.: Revenue, 2017-2019, $ billion
Table 81. Patheon Inc.: Revenue by Region in 2018
Table 82. Patheon Inc.: Recent Developments
Table 83. Pfizer CentreSource: Company Snapshot
Table 84. Pfizer CentreSource: Business Segmentation in 2018
Table 85. Pfizer CentreSource: Product Portfolio
Table 86. Pfizer CentreSource: Revenue, 2017-2019, $ billion
Table 87. Pfizer CentreSource: Revenue by Region in 2018
Table 88. Hospira, Inc. (a subsidiary of Pfizer): Company Snapshot
Table 89. Pfizer CentreSource: Recent Developments
Table 90. Sanofi: Company Snapshot
Table 91. Sanofi: Business Segmentation
Table 92. Sanofi: Revenue, 2018-2020, $ bn
Table 93. Takeda Pharmaceutical Co. Ltd.: Company Snapshot

List Of Figures

LIST OF FIGURES

Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032
Figure 4. Europe Pharmaceutical Manufacturing Industry, 2022-2032, $ mn
Figure 5. World Healthcare Services Production, annual percentage change
Figure 6. Impact of COVID-19 on Business
Figure 7. Primary Drivers and Impact Factors of Europe Pharmaceutical Manufacturing Industry
Figure 8. Trends in the Approval of Cancer Therapies by FDA in the Twenty-First Century
Figure 9. Leading Causes of Death in the World, 2000 and 2019, million
Figure 10. Worldwide Geriatric Population (60 years and above) by Region, 2015 & 2030, million
Figure 11. World Population 65 and Over, % of Total Population, 1950-2060
Figure 12. Primary Restraints and Impact Factors of Europe Pharmaceutical Manufacturing Industry
Figure 13. Investment Opportunity Analysis
Figure 14. Porter’s Fiver Forces Analysis of Europe Pharmaceutical Manufacturing Industry
Figure 15. Breakdown of Europe Pharmaceutical Manufacturing Industry by Formulation, 2022-2032, % of Revenue
Figure 16. Europe Addressable Market Cap in 2023-2032 by Formulation, Value ($ mn) and Share (%)
Figure 17. Europe Pharmaceutical Manufacturing Industry by Formulation: Tablets, 2022-2032, $ mn
Figure 18. Europe Pharmaceutical Manufacturing Industry by Formulation: Capsules, 2022-2032, $ mn
Figure 19. Europe Pharmaceutical Manufacturing Industry by Formulation: Injectable, 2022-2032, $ mn
Figure 20. Europe Pharmaceutical Manufacturing Industry by Formulation: Sprays, 2022-2032, $ mn
Figure 21. Europe Pharmaceutical Manufacturing Industry by Formulation: Suspensions, 2022-2032, $ mn
Figure 22. Europe Pharmaceutical Manufacturing Industry by Formulation: Powders, 2022-2032, $ mn
Figure 23. Europe Pharmaceutical Manufacturing Industry by Formulation: Other Formulations, 2022-2032, $ mn
Figure 24. Breakdown of Europe Pharmaceutical Manufacturing Industry by Route of Administration, 2022-2032, % of Sales Revenue
Figure 25. Europe Addressable Market Cap in 2023-2032 by Route of Administration, Value ($ mn) and Share (%)
Figure 26. Europe Pharmaceutical Manufacturing Industry by Route of Administration: Oral Medicine, 2022-2032, $ mn
Figure 27. Europe Pharmaceutical Manufacturing Industry by Route of Administration: Topical Medicine, 2022-2032, $ mn
Figure 28. Europe Pharmaceutical Manufacturing Industry by Route of Administration: Parenteral Medicine, 2022-2032, $ mn
Figure 29. Europe Pharmaceutical Manufacturing Industry by Route of Administration: Inhalations, 2022-2032, $ mn
Figure 30. Europe Pharmaceutical Manufacturing Industry by Route of Administration: Other Routes of Administration, 2022-2032, $ mn
Figure 31. Breakdown of Europe Pharmaceutical Manufacturing Industry by Consumer Group, 2022-2032, % of Sales Revenue
Figure 32. Europe Addressable Market Cap in 2023-2032 by Consumer Group, Value ($ mn) and Share (%)
Figure 33. Europe Pharmaceutical Manufacturing Industry by Consumer Group: Children & Adolescents (17 years old and below), 2022-2032, $ mn
Figure 34. Europe Pharmaceutical Manufacturing Industry by Consumer Group: Adults (18-64 years old), 2022-2032, $ mn
Figure 35. Europe Pharmaceutical Manufacturing Industry by Consumer Group: Geriatric (65 years old and above), 2022-2032, $ mn
Figure 36. Breakdown of Europe Pharmaceutical Manufacturing Industry by Therapeutic Application, 2022-2032, % of Revenue
Figure 37. Europe Addressable Market Cap in 2023-2032 by Therapeutic Application, Value ($ mn) and Share (%)
Figure 38. Europe Pharmaceutical Manufacturing Industry by Therapeutic Application: Cardiovascular Diseases, 2022-2032, $ mn
Figure 39. Europe Pharmaceutical Manufacturing Industry by Therapeutic Application: Pain, 2022-2032, $ mn
Figure 40. Europe Pharmaceutical Manufacturing Industry by Therapeutic Application: Diabetes, 2022-2032, $ mn
Figure 41. Europe Pharmaceutical Manufacturing Industry by Therapeutic Application: Cancer, 2022-2032, $ mn
Figure 42. Europe Pharmaceutical Manufacturing Industry by Therapeutic Application: Respiratory Diseases, 2022-2032, $ mn
Figure 43. Europe Pharmaceutical Manufacturing Industry by Therapeutic Application: Neurological Diseases, 2022-2032, $ mn
Figure 44. Europe Pharmaceutical Manufacturing Industry by Therapeutic Application: Orthopedics, 2022-2032, $ mn
Figure 45. Europe Pharmaceutical Manufacturing Industry by Therapeutic Application: Other Applications, 2022-2032, $ mn
Figure 46. Breakdown of Europe Pharmaceutical Manufacturing Industry by Drug Type, 2022-2032, % of Revenue
Figure 47. Europe Addressable Market Cap in 2023-2032 by Drug Type, Value ($ mn) and Share (%)
Figure 48. Europe Pharmaceutical Manufacturing Industry by Drug Type: Branded Prescription Drugs, 2022-2032, $ mn
Figure 49. Europe Pharmaceutical Manufacturing Industry by Drug Type: Generic Prescription Drugs, 2022-2032, $ mn
Figure 50. Europe Pharmaceutical Manufacturing Industry by Drug Type: OTC Drugs, 2022-2032, $ mn
Figure 51. Breakdown of Europe Pharmaceutical Manufacturing Industry by Distribution Channel, 2022-2032, % of Revenue
Figure 52. Europe Addressable Market Cap in 2023-2032 by Distribution Channel, Value ($ mn) and Share (%)
Figure 53. Europe Pharmaceutical Manufacturing Industry by Distribution Channel: Retail Channels, 2022-2032, $ mn
Figure 54. Europe Pharmaceutical Manufacturing Industry by Distribution Channel: Non-retail Channels, 2022-2032, $ mn
Figure 55. Breakdown of Europe Pharmaceutical Manufacturing Industry by Manufacturing Facility, 2022-2032, % of Revenue
Figure 56. Europe Addressable Market Cap in 2023-2032 by Manufacturing Facility, Value ($ mn) and Share (%)
Figure 57. Europe Pharmaceutical Manufacturing Industry by Manufacturing Facility: In-house Facility, 2022-2032, $ mn
Figure 58. Europe Pharmaceutical Manufacturing Industry by Manufacturing Facility: Outsourced Facility, 2022-2032, $ mn
Figure 59. Breakdown of European Pharmaceutical Manufacturing Industry by Country, 2022 and 2032, % of Revenue
Figure 60. Contribution to Europe 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 61. Pharmaceutical Manufacturing Industry in Germany, 2022-2032, $ mn
Figure 62. Pharmaceutical Manufacturing Industry in U.K., 2022-2032, $ mn
Figure 63. Pharmaceutical Manufacturing Industry in France, 2022-2032, $ mn
Figure 64. Pharmaceutical Manufacturing Industry in Spain, 2022-2032, $ mn
Figure 65. Pharmaceutical Manufacturing Industry in Italy, 2022-2032, $ mn
Figure 66. Pharmaceutical Manufacturing Industry in Netherlands, 2022-2032, $ mn
Figure 67. Pharmaceutical Manufacturing Industry in Rest of Europe, 2022-2032, $ mn
Figure 68. Growth Stage of Europe 3D Printing Industry over the Forecast Period
Figure 69. Top products of AstraZeneca based on revenue from 2016 to 2019 (in million U.S. dollars)